Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Pharnext has raised €16M across 3 funding rounds from 2 investors, most recently a round in Feb 2012. Based in Paris, France; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2012-02-01 | Other | €8.0M | Truffle Capital | View deal → |
| 2011-09-01 | Other | €2.5M | Truffle Capital | View deal → |
| 2010-06-01 | Other | €5.2M | Aurinvest | View deal → |
